MedTrace Logo

Psilocybin-assisted Interpersonal Therapy for Depression

NCT05581797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-04-09

No results posted yet for this study

Summary

This is a single-arm, open-label interventional study of psilocybin-assisted interpersonal therapy for treatment resistant depression. 20 participants will be recruited to take part in this 8-week intervention that involves 8 sessions of psychotherapy and 2 doses of psilocybin.

Conditions

  • Depressive Disorder, Treatment-Resistant

Interventions

OTHER

Psilocybin-assisted psychotherapy

8 sessions of interpersonal therapy and 2 doses of psilocybin

Sponsors & Collaborators

  • University of Otago

    lead OTHER

Principal Investigators

  • Cameron Lacey, PhD · University of Otago

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2024-05-06
Completion
2024-06-04

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05581797 on ClinicalTrials.gov